Tue, May 24, 2016
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Systematic hedge fund group Cantab Capital names Dr Matthew Killeya and Dr Genia Diamond partners

Monday, April 08, 2013

Dr. Ewan Kirk
Opalesque Industry Update - Cantab Capital Partners, the systematic global macro manager has announced that Dr Matthew Killeya (Senior Scientist) and Dr. Genia Diamond (Head of Business Development), have been named partners in the firm.

The announcement is in recognition of Dr. Killeya’s and Dr.Diamond’s contribution to Cantab’s business success and growth. Genia has lead the Investor Relations team that has overseen Cantab’s assets increase fivefold to USD 5,3 billion since 2011.

Matthew’s primary focus is on investment strategy development, having contributed strategies in all three of the clusters within the portfolio (momentum, value and short term).

Commenting on the move, Dr. Ewan Kirk said: “Our investors know that we take both our investment models and investor relations immensely seriously. Both Genia and Matthew have contributed significantly to these respective functions, as well as the overall development of Cantab. As a result we are truly pleased they have accepted our offer to join the partnership.”

Press release

Cantab Capital Partners LLP is a $5.3 billion total assets under management systematic global macro manager based in Cambridge, England. Cantab was founded in 2006 by Dr Ewan Kirk (ex-Goldman Sachs), Erich Schlaikjer (ex-Goldman Sachs) and Chris Pugh (ex-KBC). Dr Tom Howat became a Partner in 2011. The investor base is 60% institutional, 35% fund of funds, and 5% family offices/high net worth individuals. www.cantabcapital.com

Dr Genia Diamond – Head of Business Development
Genia leads the team responsible for all investor-related activities helping to further expand the firm’s reputation and place amongst investors globally.

Genia joined Cantab from OMAM UK and prior to that she was at Solent Capital and BlueCrest Capital. She started her career in asset management as a senior HF researcher at PAAMCO. Genia has a PhD in linguistics from the Moscow State University, an MBA from Erasmus University in the Netherlands and achieved an MA (honours) in Linguistics & Culture Studies from the Moscow State University.

Dr Matthew Killeya – Senior Scientist
Matthew works on all aspects of programme and portfolio construction and has driven developments in these areas, including contributing several new strategies to the portfolio.

More recently Matt’s focus has been on short term execution algorithms and strategies to trade options as a natural diversifier to the futures strategies.

Previously Matt was a senior managing researcher at Winton Capital Management for five years. Matt has a PhD in Bayesian statistics from Durham University. Prior to that, Matt obtained a first class Master of Mathematics degree, also from Durham University.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other voices: What current trends tell us about the future of the hedge fund industry[more]

    By: Don Steinbrugge, Agecroft Partners The following comments are excerpted from Agecroft Partners’ Don Steinbrugge’s presentation delivered at the 69th CFA Institute Annual Conference held on May 9th, 2016 in Montreal. In Mr. Steinbrugge’s session titled "What Current Trends Tell Us about th

  2. Investing - Steve Cohen boosted Sotheby’s stake to $86 million last quarter, Larry Robbins' hedge fund sells off all CHS, UHS hospital stocks, Tiger Global cut stakes in Amazon, JD.com, Apple last quarter, Invest in real estate near biotech hubs, Prudential’s Hyat says, Valeant: A hedge fund hotel wrecking ball[more]

    Steve Cohen boosted Sotheby’s stake to $86 million last quarter Billionaire trader and art collector Steve Cohen is on a buying spree of Sotheby’s shares. Cohen’s Point72 Asset Management acquired 1.2 million Sotheby’s shares, bringing its total to 3.2 million valued at $86.1 million at

  3. Legal - Boaz Weinstein wins round in fight with Canada’s PSP[more]

    From FT.com: Boaz Weinstein, the hedge fund manager credited with spotting JPMorgan’s “London Whale” in 2012, has won a round in a legal battle with Canada’s Public Sector Pension Investment Board that had become a test case of responsibilities when clients withdraw money. PSP sued Mr Weinstein and

  4. Regulatory - The latest Fannie and Freddie reform bill offers a bonanza for hedge funds[more]

    From WSJ.com: The latest housing finance reform bill making the rounds on Capitol Hill offers a bonanza for hedge funds seeking to cash in on their investments in Fannie Mae Mae and Freddie Mac—but the cost to taxpayers would be steep. Congressman Mick Mulvaney, the South Carolina Republican, introd

  5. West Virginia objects to Alpha Natural sale to hedge fund[more]

    From AP/Heraldcourier.com: West Virginia's environmental authority has filed an objection to the proposed $500 million sale of Alpha Natural Resources' assets to a hedge fund, arguing that the deal could leave the state holding hundreds of millions in reclamation liabilities. The Register-Hera